Health economic evaluation of ticagrelor compared to generic clopidogrel in patients with acute coronary syndromes intended for non-invasive management based on the PLATO trial

被引：0
|
作者：
James, S. [1 ]
Storey, R. F. [2 ]
Cannon, C. [3 ]
Janzon, M. [4 ]
Nicolau, J. C. [5 ]
Parasuraman, B. [6 ]
Mellstrom, K. [7 ]
Wallentin, L. [1 ]
Henriksson, M. [7 ]
机构：
[1] Uppsala Univ, UCR Uppsala Clin Res Ctr, Uppsala, Sweden
[2] Univ Sheffield, Dept Cardiovasc Sci, Sheffield, S Yorkshire, England
[3] Brigham & Womens Hosp, Dept Med, Div Cardiovasc, TIMI Study Grp, Boston, MA 02115 USA
[4] Linkoping Univ, Dept Med & Hlth Sci, Div Cardiovasc Med, Linkoping, Sweden
[5] Univ Sao Paulo Fac Med FMUSP, Heart Inst InCor, Sao Paulo, Brazil
[6] Astra Zeneca, Wilmington, DE USA
[7] Astra Zeneca, Sodertalje, Sweden
来源：
EUROPEAN HEART JOURNAL | 2013年 / 34卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：896 / 896
页数：1
相关论文
共 50 条
  • [41] Response to Letter Regarding Article, "Stent Thrombosis With Ticagrelor Versus Clopidogrel in Patients With Acute Coronary Syndromes: An Analysis From the Prospective, Randomized PLATO Trial"
    Steg, P. Gabriel
    Harrington, Robert A.
    Emanuelsson, Hakan
    Katus, Hugo A.
    Mahaffey, Kenneth W.
    Meier, Bernhard
    Storey, Robert F.
    Wojdyla, Daniel M.
    Lewis, Basil S.
    Maurer, Gerald
    Wallentin, Lars
    James, Stefan K.
    CIRCULATION, 2014, 129 (19) : E494 - E495
  • [42] More Rapid and Consistent Inhibition of Platelet Aggregation is Achieved by Loading With Ticagrelor Compared to Clopidogrel in Patients With Acute Coronary Syndromes: Results From the PLATO PLATELET Substudy
    Storey, Robert F.
    Patil, Shankar B.
    Ecob, Rosemary
    Angiolillo, Dominick J.
    Wallentin, Lars
    CIRCULATION, 2009, 120 (18) : S1102 - S1102
  • [43] Ticagrelor Versus Clopidogrel in Acute Coronary Syndromes in Relation to Renal Function Results From the Platelet Inhibition and Patient Outcomes (PLATO) Trial
    James, Stefan
    Budaj, Andrzej
    Aylward, Philip
    Buck, Kristen K.
    Cannon, Christopher P.
    Cornel, Jan H.
    Harrington, Robert A.
    Horrow, Jay
    Katus, Hugo
    Keltai, Matyas
    Lewis, Basil S.
    Parikh, Keyur
    Storey, Robert F.
    Szummer, Karolina
    Wojdyla, Daniel
    Wallentin, Lars
    CIRCULATION, 2010, 122 (11) : 1056 - 1067
  • [44] TICAGRELOR VERSUS CLOPIDOGREL IN WOMEN WITH ACUTE CORONARY SYNDROMES - A SUBSTUDY FROM THE PROSPECTIVE RANDOMIZED PLATELET INHIBITION AND PATIENT OUTCOMES (PLATO) TRIAL
    Husted, Steen
    James, Stefan
    Becker, Richard
    Horrow, Jay
    Katus, Hugo
    Storey, Robert
    Cannon, Christopher
    Heras, Magda
    Lopes, Renato
    Morais, Joao
    Mahaffey, Kenneth
    Bach, Richard
    Wojdyla, Daniel
    Wallentin, Lars
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2012, 59 (13) : E507 - E507
  • [45] Lifetime cost-effectiveness analysis of ticagrelor in patients with acute coronary syndromes based on the PLATO trial: a Singapore healthcare perspective
    Chin, Chee Tang
    Mellstrom, Carl
    Chua, Terrance Siang Jin
    Matchar, David Bruce
    SINGAPORE MEDICAL JOURNAL, 2013, 54 (03) : 169 - 175
  • [46] Ticagrelor vs. clopidogrel in patients with non-ST-elevation acute coronary syndrome with or without revascularization: results from the PLATO trial
    Lindholm, Daniel
    Varenhorst, Christoph
    Cannon, Christopher P.
    Harrington, Robert A.
    Himmelmann, Anders
    Maya, Juan
    Husted, Steen
    Steg, Philippe Gabriel
    Cornel, Jan H.
    Storey, Robert F.
    Stevens, Susanna R.
    Wallentin, Lars
    James, Stefan K.
    EUROPEAN HEART JOURNAL, 2014, 35 (31) : 2083 - 2093
  • [47] Letter by Roguin and Musallam Regarding Article, "Stent Thrombosis With Ticagrelor Versus Clopidogrel in Patients With Acute Coronary Syndromes: An Analysis From the Prospective, Randomized PLATO Trial"
    Roguin, Ariel
    Musallam, Anees
    CIRCULATION, 2014, 129 (19) : E493 - E493
  • [48] Direct healthcare costs and cost-effectiveness of acute coronary syndrome secondary prevention with ticagrelor compared to clopidogrel: economic evaluation from the public payer's perspective in Poland based on the PLATO trial results
    Paweska, Justyna
    Macioch, Tomasz
    Perkowski, Piotr
    Budaj, Andrzej
    Niewada, Maciej
    KARDIOLOGIA POLSKA, 2014, 72 (09) : 823 - 830
  • [49] PLATO-Invasive: Comparison of Ticagrelor, the first reversible oral P2Y12 receptor antagonist, with clopidogrel in patients with acute coronary syndromes with a planned invasive strategy: Results of the PLATelet inhibition and patient Outcomes (PLATO) trial
    Cannon, Christopher P.
    Becker, Richard
    Emanuelsson, Hakan
    Harrington, Robert
    Horrow, Jay
    Husted, Steen
    Katus, Hugo
    Steg, Philippe Gabriel
    Storey, Robert F.
    Wallentin, Lars
    AMERICAN JOURNAL OF CARDIOLOGY, 2009, 104 (6A): : XVIII - XVIII
  • [50] Maintenance Treatment With Ticagrelor Yields Greater and More Consistent Inhibition of Platelet Function Compared to Clopidogrel in Patients With Acute Coronary Syndromes: Results From the PLATO PLATELET Substudy
    Storey, Robert F.
    Angiolillo, Dominick J.
    Patil, Shankar B.
    Desai, Bhaloo
    Husted, Steen
    Emanuelsson, Hakan
    Wallentin, Lars
    CIRCULATION, 2009, 120 (18) : S1027 - S1027
12345